BR112015007577A2 - métodos para cultivar sebócitos primários e identificar compostos que regulam a lipogênese e população isolada de sebócitos cultivados - Google Patents
métodos para cultivar sebócitos primários e identificar compostos que regulam a lipogênese e população isolada de sebócitos cultivadosInfo
- Publication number
- BR112015007577A2 BR112015007577A2 BR112015007577A BR112015007577A BR112015007577A2 BR 112015007577 A2 BR112015007577 A2 BR 112015007577A2 BR 112015007577 A BR112015007577 A BR 112015007577A BR 112015007577 A BR112015007577 A BR 112015007577A BR 112015007577 A2 BR112015007577 A2 BR 112015007577A2
- Authority
- BR
- Brazil
- Prior art keywords
- sebocytes
- methods
- cultured
- identifying compounds
- isolated population
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0625—Epidermal cells, skin cells; Cells of the oral mucosa
- C12N5/0633—Cells of secretory glands, e.g. parotid gland, salivary glands, sweat glands, lacrymal glands
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/10—Mineral substrates
- C12N2533/12—Glass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Abstract
métodos para cultivar sebócitos primários e identificar compostos que regulam a lipogênese e população isolada de sebócitos cultivados resumo trata-se de métodos para cultivar sebócitos, populações isoladas de sebócitos e métodos para usar as sebócitos cultivadas para triar compostos que inibam ou ativem a lipogênese. 2/1 1/1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261710359P | 2012-10-05 | 2012-10-05 | |
US201361765861P | 2013-02-18 | 2013-02-18 | |
PCT/US2013/063367 WO2014055815A1 (en) | 2012-10-05 | 2013-10-04 | Sebocyte cell culturing and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112015007577A2 true BR112015007577A2 (pt) | 2017-12-12 |
Family
ID=50435450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015007577A BR112015007577A2 (pt) | 2012-10-05 | 2013-10-04 | métodos para cultivar sebócitos primários e identificar compostos que regulam a lipogênese e população isolada de sebócitos cultivados |
Country Status (7)
Country | Link |
---|---|
US (1) | US20150268254A1 (pt) |
EP (1) | EP2904095A4 (pt) |
JP (1) | JP2015530122A (pt) |
CN (1) | CN105247040A (pt) |
BR (1) | BR112015007577A2 (pt) |
SG (1) | SG11201502497RA (pt) |
WO (1) | WO2014055815A1 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10478526B2 (en) * | 2013-05-03 | 2019-11-19 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Skin substitutes and methods for hair follicle neogenesis |
WO2017138078A1 (ja) * | 2016-02-08 | 2017-08-17 | 花王株式会社 | 成熟皮脂腺細胞の製造方法 |
FR3061205A1 (fr) * | 2016-12-22 | 2018-06-29 | L'oreal | Modele d'epithelium reconstruit sebocytaire differencie a partir de sebocytes humains primaires |
US20200003756A1 (en) * | 2017-04-20 | 2020-01-02 | Mandom Corporation | Method for observing sebaceous gland |
JP6692593B1 (ja) * | 2018-10-17 | 2020-05-13 | 株式会社マンダム | 皮脂腺の観察方法およびその利用 |
CN109852576A (zh) * | 2019-01-07 | 2019-06-07 | 施歌 | 一种永生化皮脂腺细胞株的构建方法 |
CN111088217B (zh) * | 2019-12-20 | 2023-03-03 | 广东博溪生物科技有限公司 | 细胞培养基、细胞培养试剂盒及细胞培养方法 |
CN112608947B (zh) * | 2020-12-28 | 2023-06-16 | 上海市皮肤病医院 | 一种永生化人皮脂腺细胞系的构建方法及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5762947A (en) * | 1997-05-09 | 1998-06-09 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic skin conditioning compositions containing a salicyloxy α-carboxy acid |
JP2008307007A (ja) * | 2007-06-15 | 2008-12-25 | Bayer Schering Pharma Ag | 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞 |
-
2013
- 2013-10-04 EP EP13844517.6A patent/EP2904095A4/en not_active Withdrawn
- 2013-10-04 CN CN201380060511.6A patent/CN105247040A/zh active Pending
- 2013-10-04 US US14/433,507 patent/US20150268254A1/en not_active Abandoned
- 2013-10-04 SG SG11201502497RA patent/SG11201502497RA/en unknown
- 2013-10-04 BR BR112015007577A patent/BR112015007577A2/pt not_active IP Right Cessation
- 2013-10-04 WO PCT/US2013/063367 patent/WO2014055815A1/en active Application Filing
- 2013-10-04 JP JP2015535800A patent/JP2015530122A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP2904095A4 (en) | 2016-03-30 |
CN105247040A (zh) | 2016-01-13 |
EP2904095A1 (en) | 2015-08-12 |
JP2015530122A (ja) | 2015-10-15 |
US20150268254A1 (en) | 2015-09-24 |
WO2014055815A1 (en) | 2014-04-10 |
SG11201502497RA (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112015007577A2 (pt) | métodos para cultivar sebócitos primários e identificar compostos que regulam a lipogênese e população isolada de sebócitos cultivados | |
UY34697A (es) | Métodos para preparar análogos de nucleótidos | |
UY34374A (es) | Benzilindazoles sustituidos | |
CR20150600A (es) | Proceso de producción de biomasa y metabolitos de microorganismos de la especie bacilus sp. y sus composiciones para el control biologico de plagas | |
UY34515A (es) | Triazolopiridinas sustituidas | |
UY34156A (es) | Compuestos inhibidores de metaloenzimas | |
UY34445A (es) | Nuevos compuestos inhibidores de la fosfodiesterasa del tipo 10a | |
BR112016012883A2 (pt) | Métodos e composições para aprimorar o rendimento de milho | |
UY34683A (es) | Esteviol glucosiltransferasas y genes que las codifican | |
UY34817A (es) | Tienopirimidinas | |
UY34484A (es) | Benzotienilo-pirrolotriazinas disustituidas y sus usos | |
UY4211Q (es) | Pizarra para marcadores | |
UY34573A (es) | Inhibidor de la quinasa que regula la señal de la apoptosis | |
BR112016028370A2 (pt) | compostos de ácido 3,6-diclorossa¬licílico e processos sintéticos relacionados | |
UY33750A (es) | ?Compuestos insecticidas aromáticos derivados de bisamida, procesos e intermediarios para prepararlos y composiciones que los usan.? | |
MX350773B (es) | Métodos y composiciones para el control de malezas. | |
UY34034A (es) | Triazolopiridinas | |
UY34336A (es) | Derivados 5-fluoro pirimidina disustituidos que contienen un grupo sulfoximina | |
UY34006A (es) | Imidazopiridazinas | |
UY34027A (es) | Inhibidores sustituidos de acetil-coa carboxilasa. | |
EA201591057A1 (ru) | Штамм bifidobacterium animalis ssp. animalis | |
EA201290921A1 (ru) | Гербицидостойкие растения | |
BR112015009042A8 (pt) | Método para identificar uma população de célula renal heterogênea adequada para implantação e/ou desencadeamento de uma resposta regenerativa | |
UY4153Q (es) | Batería | |
UY4213Q (es) | Centro de distribución de energía |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2482 DE 31-07-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] |